blue cross blue shield glp 1 of Mass. sees gains after years of GLP-1-related losses IBX members face GLP-1 drug

Endocr Pract 2018

Employers want to offer something for their members, but when they see the cost, they cant afford it. Employers who address obesity treatment effectively can drive significant value in their costs and employee satisfaction. Elina Onitskansky, founder and CEO, Ilant Health Weighing the Long-Term Benefits While GLP-1 drugs were originally developed to treat diabetes by managing blood sugar levels, they now are commonly prescribed to also treat obesity

Do not use Wegovy, Ozempic, Zepbound, or Compounded Liraglutide if you are currently pregnant, breastfeeding, or plan to become pregnant or breastfeed

10.1007/s00125-014-3231-y [DOI] [PubMed] [Google Scholar] 47.Pinto LC, Rados DV, Barkan SS, Leitao CB, Gross JL